Oct 19, 2016 by Brian Orelli, PhDWhy Puma Biotechnology Inc. Sold Lower TodayInvestors send shares lower after the biotech announces a secondary offering.
Oct 17, 2016 by Brian Orelli, PhDWhy Lannett Company, Inc. Shares Got Pummeled TodayThe FDA proposes to withdraw one of the company's generic drugs.
Oct 14, 2016 by Brian Orelli, PhDWhy Shares of bluebird bio Inc Took a Dive TodayInvestors sell the news after the company's R&D day leaves the biotech without a near-term catalyst.
Oct 13, 2016 by Brian Orelli, PhDExelixis Goes for ItThe biotech plans to expand the potential patient pool for Cabometyx, but the plan isn't without complications.
Oct 11, 2016 by Brian Orelli, PhDWhy Momenta Pharmaceuticals, Inc. Jumped Higher TodayAn analyst upgraded the biotech ahead of some key value-infection points.
Oct 10, 2016 by Brian Orelli, PhDWhy Myriad Genetics, Inc. Got Crushed TodayWhen a drug helps everyone, a companion test isn't all that useful.
Oct 6, 2016 by Brian Orelli, PhDWhy The Medicines Company's Share Price Got Sick TodayThe drugmaker gets infected by problems with its partner's program.
Oct 5, 2016 by Brian Orelli, PhDWhy Corbus Pharmaceuticals Holdings Inc Shares Skyrocketed TodayA new analyst rating for an underfollowed biotech.
Oct 4, 2016 by Brian Orelli, PhDWhy Celldex Therapeutics, Inc. Jumped Higher TodayAn analyst initiates a buy rating, but investors may be buying in anticipation of data at the European Society for Medical Oncology meeting next week.
Sep 30, 2016 by Brian Orelli, PhDWhy Emergent Biosolutions Inc Surged Higher TodayThe company provides two updates on the government's plans to buy its anthrax vaccines.
Sep 29, 2016 by Brian Orelli, PhDWhy Exelixis, Inc. Continued Its Downfall TodayWaiting for data is never easy.
Sep 28, 2016 by Brian Orelli, PhDWhy Exelixis, Inc. Got Hammered TodayData from a competitor drives the stock down.
Sep 28, 2016 by Brian Orelli, PhDWhy Anavex Life Sciences Corp. Rocketed Higher TodayBiogen explorers the potential of Anavex's lead drug.
Sep 27, 2016 by Brian Orelli, PhDWhy Celldex Therapeutics, Inc. Ran Higher TodayInvestors await clinical trial data.
Sep 26, 2016 by Brian Orelli, PhDWhy Natus Medical Inc Slipped TodayThe medical equipment maker makes an acquisition to spur growth, but investors are focused on the current quarter.
Sep 23, 2016 by Brian Orelli, PhDWhy Endo International plc Jumped Higher TodayThe drugmaker gets a new boss.
Sep 22, 2016 by Brian Orelli, PhDGilead Sciences Inc.'s Biggest Win in 2016 So FarA bright spot in the otherwise dismal year for the biotech.
Sep 22, 2016 by Brian Orelli, PhDGW Pharmaceuticals in 5 ChartsThe marijuana-drug company has had quite the year.
Sep 20, 2016 by Brian Orelli, PhDWhy Tobira Therapeutics Inc Was an Overnight OctupleIt's not every day you see a biotech go up by more than 700%.
Sep 20, 2016 by Brian Orelli, PhDWhy Puma Biotechnology Inc Roared Higher TodayThe FDA accepts the biotech's marketing application, which probably shouldn't cause as big of a jump as it did.
